Mode
Text Size
Log in / Sign up
Phase 4 N=23 Treatment

Treating Caregivers Who Smoke at AFCH

Smoking · Smoking Cessation

Enrolled (actual)
23
Serious AEs
0.0%
Results posted
Apr 2026
Primary outcome: Primary: Enrollment in Study — 36.5 percentage of people invited who enrolle

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
Nicotine Replacement Product (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Wisconsin, Madison
Primary completion
Apr 2025

Outcome Measures

OutcomeResultp-value
PRIMARY
Enrollment in Study
36.5
PRIMARY
NRT Use
11
PRIMARY
Acceptability of Smoking Intervention
6.77
SECONDARY
Change in Number of Cigarettes Smoked Per Day
-6.31
SECONDARY
Change in Trips Outside
-0.5
SECONDARY
Change in Self-confidence in Quitting Smoking
0.64
SECONDARY
Change in Motivation to Quit Smoking
0.93

Summary

The purpose of this research study is to 1) see if a smoking cessation program is something that caregivers will use while their child is hospitalized, 2) see if caregivers think this program is something we should institute across the hospital, and 3) see if this program can help caregivers reduce their smoking. Participants will: * Complete a survey regarding smoking behavior and thoughts about quitting; * Undergo a 20-minute counseling session; and, * Use nicotine patches and mini-lozenges for 2 weeks

Eligibility Criteria

Inclusion Criteria

  • Hospitalized child will have a 'yes' response to the screening question, "Does anyone in your household smoke"
  • Hospitalized child is expected to be admitted for >24 hours
  • Caregiver is at least 18 years of age
  • Participant self-identifies as the primary caregiver of the hospitalized child during the hospitalization
  • Participant smokes ≥5 cigarettes per day
  • Participant is willing and able to use NRT
  • Participant is not currently pregnant, trying to get pregnant, or breastfeeding and willing to use acceptable birth control for duration of medication use
  • Participant is willing to comply with all study procedures and be available for the duration of the study

Exclusion Criteria

  • Contraindication to NRT use (pregnancy, myocardial infarction in past 2 weeks)
  • Previous reaction to the nicotine patch or mini-lozenge that prevented them from continuing to use it
  • Current use of smoking cessation medications (any NRT, bupropion, varenicline)
  • Caregiver's child is being cared for by study physician (Dr. Brian Williams)
  • Need for an interpreter
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT06051474). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search